期刊文献+

代谢综合征及其相关指标与结直肠腺瘤发生的关系 被引量:22

Association of colorectai adenoma and metabolic syndrome and relevant parameters
原文传递
导出
摘要 目的探讨代谢综合征及其相关指标与结直肠腺瘤发生的关系。方法回顾性分析2014年1月至2015年6月间在香港大学深圳医院接受结肠镜检查的289例患者临床资料,其中130例结肠镜检查未发现异常(正常组);159例经病理证实为结直肠腺瘤(腺瘤组)。比较两组患者代谢综合征相关指标(包括体质指数、腰围、臀围、血糖、甘油三酯、高密度脂蛋白、胆固醇)的水平,并分析代谢综合征及其相关代谢性疾病与结直肠腺瘤发生的关系。结果两组患者在性别、年龄、吸烟史、长期饮酒史、规律运动、结直肠癌家族史及长期服用非甾体类抗炎药物史方面的差异均无统计学意义(P〉0.05)。与正常组相比,腺瘤组患者的体质指数大[(23.5±3.2)kg/m^2比(22.7±2.8)kg/m^2,t=1.97,P=0.050],腰围长[(83.4±10.3)cm比(79.6±13.8)cm,t=2.46,P=0.015],血清高密度脂蛋白[(1.3±0.3)mmol/L比(1.2±0.3)mmol/L,t=2.03,P=0.044]及胆固醇水平高[(5.4±1.O)mm0L/L比(5.0±1.1)mmol/L,t=2.39,P=0.018];而两组患者臀围、腰围臀围比、空腹血糖及甘油三酯水平的差异均无统计学意义(均P〉O.05)。代谢综合征[69.8%(37/53)比51.7%(122/236),P=0.017]、超重或肥胖[65.1%(56/86)比50.7%(103/203),P=0.025]、高血压[67.3%(37/55)比52.1%(122/234),P=0.046]及高胆固醇血症[66.7%(64/96)比49.2%(95/193),P=0.005]患者结直肠腺瘤发生率明显更高。结论代谢综合征患者发生结直肠腺瘤的风险增加,其机制可能与血清胆固醇和高密度脂蛋白水平升高所致的胆固醇分解代谢增强有关。有必要加强对代谢综合征,尤其是中心型肥胖及高胆固醇血症的人群进行结肠镜筛查,以早期发现、早期治疗结直肠腺瘤。 Objective To evaluate the association of colorectal adenoma with metabolic syndrome (MS) and relevant parameters. Methods Clinical data of 289 subjects who underwent screening colonoscopy in the University of Hong Kong-Shenzhen Hospital from January 2014 to June 2015 were retrospectively analyzed, including 130 normal subjects (normal group) and 159 cases with colorectal adenoma confirmed by pathology (adenoma group). Levels of MS-associated parameters were compared between the two groups, and the association of metabolic diseases with colorectal adenoma was examined. Results The gender, smoking and drinking habit, regular physical activity, family history of colorectal cancer, and consumption history of long-term non-steroidal anti-inflammatory drugs were not significantly different between two groups (all P 〉 0.05). As compared to normal group, adenoma group had higher body mass index (BMI)[(23.5 ± 3.2)kg/m^2 vs. (22.7±2.8)kg/m^2, t = 1.97, P= 0.050], larger abdominal circumference [(83.4± 10.3) cm vs. (79.6 ±13.8) cm, t = 2.46, P = 0.015], higher serum high-density lipoprotein level [( 1.3 ± 0.3) mmol/L vs. (1.2 ± 0.3) mmol/L, t = 2.03, P= 0.044], and higher serum cholesterol [(5.4 ± 1.0) mmol/L vs. (5.0 ± 1.1) mmol/L, t = 2.39, P = 0.018]. No significant difference was demonstrated in comparing hip circumference and waist-hip ratio, as well as serum fasting glucose and triglyceride (all P 〉 0.05). Higher incidence of colorectal adenoma was found in subjects with MS [69.8%(37/53) vs. 1.7%(122/236), P = 0.017], overweight or obesity [65.1% (56/86) vs. 50.7%(103/203), P = 0.025], hypertension [67.3%(37/55) vs. 52.1%(122/234), P = 0.046] and hypercholesterolemia [66.7%(64/96) vs. 49.2% (95/193), P = 0.005]. Coclusions Metabolic syndrome increased the risk of developing colorectal adenoma. The mechanism may be related to higher serum cholesterol and high density lipoprotein, which may lead to the elevated catabolism
出处 《中华胃肠外科杂志》 CAS CSCD 北大核心 2016年第6期675-679,共5页 Chinese Journal of Gastrointestinal Surgery
基金 国家青年科学基金(81100325)
关键词 结直肠腺瘤 代谢综合征 胆固醇异常 Colorectal adenoma Metabolic syndrome Cholesterol
  • 相关文献

参考文献22

  • 1World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complication[DB/OL]. WHO/NCD/ NCS/992,31-32. 被引量:1
  • 2Ahmed RL, Schmitz KH, Anderson KE, et al. The metabolic syndrome and risk of incident colorectal cancer [J]. Cancer, 2006,107 ( 1 ) : 28-36. DOI : 10.1002/cncr.21950. 被引量:1
  • 3Sun L, Yu S. Diabetes mellitus is an independent risk factor for colorectal cancer [J]. Dig Dis Sci, 2012, 57(6) : 1586-1597. DOI : 10.1007/s10620-012-2059-x. 被引量:1
  • 4Kang HW, Kim D, Kim HJ, et al. Visceral obesity and insulin resistance as risk factors for colorectal adenoma: a cross- sectional, case control study. Am J Gastroenterol, 2009,105 ( 1 ) : 178-187. DOI: 10.1038/ajg.2009.541. 被引量:1
  • 5中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3053
  • 6Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Pand ~ ). Executive summary of the third report of the national cholesterol education program (NCEP) [ J ]. JAMA, 2001,285 (19) : 2486- 2497. DOI: 10.1001/jama.285.19.2496. 被引量:1
  • 7The European Group for the Study of Insulin Resistance (EGIR). Frequency of the WHO metabolic syndromein Euro- pean cohorts, and an alternative definition of an insulin resistance syndrome [J]. Diabetes Metab, 2002,28 (5):364- 376. DOI : DM-11-2002-28-5-1262-3636-101019-ART3. 被引量:1
  • 8Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition[J]. Lancet, 2005,366(9491) : 1059-1062. DOI: 10.1016/ S0140-6736(05 )67402-8. 被引量:1
  • 9卢艳慧,陆菊明,王淑玉,李春霖,刘力生,郑润平,田慧,王先令,杨丽娟,张育青,潘长玉.国际糖尿病联盟与中国糖尿病学会关于代谢综合征诊断标准的比较分析[J].中华医学杂志,2006,86(6):386-389. 被引量:78
  • 10Reynolds K, He J. Epidemiology of the metabolic syndrome[J]. Am J Med Sci, 2005,330 (6) :273-279. DOI: 10.1097/00000441- 200512000-00(0. 被引量:1

二级参考文献15

  • 1中华医学会糖尿病学分会代谢综合征研究协作组.中华医学会糖尿病学分会关于代谢综合征的建议[J].中国糖尿病杂志,2004,12(3):156-161. 被引量:3053
  • 2Isomaa B,Almgren P,Tuomi T,et al.Cardiovascular morbidity and mortality associated with the metabolic syndrome.Diabetes Care,2001,24:683-689. 被引量:1
  • 3Ridker PM,Burning JE,Cook NR,et al.C-reactive Protein,the metabolic syndrome,and risk of incident cardiovascular events.An 8-year follow-up of 14719 initially healthy American women.Circulation,2003,107:391-397. 被引量:1
  • 4Baltali M,Gokcel A,Kiziltan HT,et al.Association between the metabolic syndrome and newly diagnosed coronary artery disease.Diabetes Nutr Metab,2003,16:169-175. 被引量:1
  • 5International Diabetes Federation.The IDF consensus worldwide definition of the metabolic syndrome.Berlin,2005.14. 被引量:1
  • 6World Health Organization.Definition,diagnosis and classification of diabetes mellitus and its complication.WHO/NCD/NCS,1999.31-32. 被引量:1
  • 7Expert Panel on Detection,Evaluation,and treatment of high blood cholesterol in adults.executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert panel on detection,evaluation,and treatment of high blood cholesterol in adults (adult treatment panel Ⅲ).JAMA,2001,285:2486-2497. 被引量:1
  • 8Alexander CM,Landsman PB,teutsch SM,et al.NCEP-defined metabolic syndrome,diabetes,and prevalence of coronary heart disease among NHANES Ⅲ participants age 50 years and older.Diabetes,2003,52:1210-1214. 被引量:1
  • 9The European Group for the study of Insulin Resistance (EGIR).frequency of the WHO metabolic syndrome in european cohorts,and an alternative definition of an insulin resistance syndrome..Diabetes Metab,2002,2:354-376. 被引量:1
  • 10周北凡,武阳丰,赵连成,李莹,杨军,李贤.我国中年人群向心性肥胖和心血管病危险因素及其聚集性[J].中华心血管病杂志,2001,29(2):70-73. 被引量:110

共引文献3575

同被引文献179

引证文献22

二级引证文献94

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部